T
Timothy Mosbruger
Researcher at Children's Hospital of Philadelphia
Publications - 14
Citations - 141
Timothy Mosbruger is an academic researcher from Children's Hospital of Philadelphia. The author has contributed to research in topics: Population & Nanopore sequencing. The author has an hindex of 5, co-authored 14 publications receiving 71 citations. Previous affiliations of Timothy Mosbruger include University of Pennsylvania.
Papers
More filters
Journal ArticleDOI
Utilizing nanopore sequencing technology for the rapid and comprehensive characterization of eleven HLA loci; addressing the need for deceased donor expedited HLA typing.
Timothy Mosbruger,Amalia Dinou,Jamie L. Duke,Deborah Ferriola,Hilary Mehler,Ioanna Pagkrati,Georgios Damianos,Eric Mbunwe,Mahdi Sarmady,Ioannis Lyratzakis,Sarah A. Tishkoff,Anh Dinh,Dimitri S. Monos,Dimitri S. Monos +13 more
TL;DR: The results demonstrate the potential of nanopore sequencing for delivering accurate HR-3F typing with a simple, rapid, and cost-effective protocol and appears to offer a significant advancement over current next-generation sequencing platforms as a single solution for all HLA genotyping needs.
Journal ArticleDOI
Assessing the utilization of high‐resolution 2‐field HLA typing in solid organ transplantation
Yanping Huang,Anh Dinh,S. Heron,Allison Gasiewski,Carolina Kneib,Hilary Mehler,Michael T. Mignogno,Ryan Morlen,Larissa Slavich,Ethan Kentzel,Edward C. Frackelton,Jamie L. Duke,Deborah Ferriola,Timothy Mosbruger,Olga A. Timofeeva,Steven S. Geier,Dimitri S. Monos,Dimitri S. Monos +17 more
TL;DR: The role of high‐resolution 2‐field HLA typing (HR‐2F) in SOT is assessed by retrospectively evaluating NGS‐typed pre‐ and post‐SOT cases, whereby 21% of the cases required HR‐ 2F typing by Sanger sequencing, as supported by other legacy methods, to properly address posttransplant anti‐HLA antibody issues.
Journal ArticleDOI
Next-generation HLA typing of 382 International Histocompatibility Working Group reference B-lymphoblastoid cell lines: Report from the 17th International HLA and Immunogenetics Workshop.
Lisa E. Creary,Sandra G. Guerra,Winnie Chong,Colin Brown,Thomas R. Turner,James Robinson,WP Bultitude,Neema P. Mayor,Steven G.E. Marsh,Katsuyuki Saito,Kevin Lam,Jamie L. Duke,Timothy Mosbruger,Deborah Ferriola,Dimitrios Monos,Amanda Willis,Medhat Askar,Gottfried Fischer,Chee Loong Saw,Jiannis Ragoussis,Martin Petrek,Carles Serra-Pagès,Manel Juan,Catherine Stavropoulos-Giokas,Amalia Dinou,Reem Ameen,Salem Al Shemmari,Eric Spierings,Ketevan Gendzekhadze,Gerald P. Morris,Qiuheng Zhang,Zahra Kashi,Susan Hsu,Sridevi Gangavarapu,Kalyan C. Mallempati,Fumiko Yamamoto,Kazutoyo Osoegawa,Tamara Vayntrub,Chia-Jung Chang,John A. Hansen,Marcelo A. Fernández-Viňa +40 more
TL;DR: The authors' approach of multiple-laboratory NGS HLA typing of the B-LCLs has provided accurate genotyping data and is useful for updating the current cell and sequence databases and will be a valuable resource for future studies.
Journal ArticleDOI
Resolving MiSeq-Generated Ambiguities in HLA-DPB1 Typing by Using the Oxford Nanopore Technology.
Jamie L. Duke,Timothy Mosbruger,Deborah Ferriola,Nilesh Chitnis,Taishan Hu,Nikolaos Tairis,David J. Margolis,Dimitri S. Monos,Dimitri S. Monos +8 more
TL;DR: Oxford Nanopore, a third generation sequencing technology, was used to resolve the phasing of exonic heterozygous positions between exon 2 and all other downstream exons and the accurate MiSeq sequencing data combined with the long reads obtained from the MinION platform of Nanobore technology allows for the resolution of the tested ambiguities.
Journal ArticleDOI
Characterization of 108 Genomic DNA Reference Materials for 11 Human Leukocyte Antigen Loci: A GeT-RM Collaborative Project.
Maria Bettinotti,Deborah Ferriola,Jamie L. Duke,Timothy Mosbruger,Nikolaos Tairis,Lawrence J. Jennings,Lisa V. Kalman,Dimitri S. Monos,Dimitri S. Monos +8 more
TL;DR: The goal was to develop a publicly available and renewable source of well-characterized genomic DNA reference materials to support molecular HLA typing assay development, validation, and verification, quality control, and proficiency testing.